Welcome Home Prozac Weight Gain Glutathione Antidepressants Benzodiazepines Other Medications Site Map
Click here for the Free E-book How to Get Off Psychoactive Drugs Safely
Review by Dr. Hyla Cass M.D. Psychiatrist "Here is an essential handbook on how to safely and more easily wean yourself (under medical supervision) off the heavily over-prescribed psychotropic medications. I have used the program with my patients and it works!” Hyla Cass M.D. Author of   Supplement Your Prescription The latest edition of How to  Get Off Psychotropic  Drugs Safely, is now  available as an e-book and  at Amazon.com. This  bestselling book details  what to do to avoid Prozac  withdrawal side effects,  what you can do to  eliminate existing Prozac  withdrawal side effects and  how to reduce the Prozac  safely. Click here for the  E-book which allows you  to receive the book  instantly! 
There is a Solution There is Hope
Physician’s Resource The physician’s psychoactive medication resource guide 25% of your patients taking an antidepressant will have weight gain and the weight gain is directly caused by the antidepressant.
Abilify Clinical Trials Getting off Abilify and getting rid of the Abilify side effects can be accomplished. The agitation, anxiety, insomnia and other symptoms can be reduced greatly or completely eliminated. Abilify and other antipsychotic medications are known to cause diabetes. There is a solution. Get your patients the book How to Get Off Psychoactive Drugs Safely and start living a more complete life quickly. Click here to go to Amazon.com. Abilify Below you will find current clinical studies on Abilify Aripiprazole Add-On Treatment in a Patient with Schizoaffective Disorder: Neurocognitive Outcomes. Pfaffenberger N, Hoertnagl C, Fleischhacker WW, Hofer A. Pharmacopsychiatry. 2010 May 25. [Epub ahead of print] No abstract available. Abilify: 20503152 [Abilify - as supplied by publisher]Related Abilify Citations Effectiveness of switching from aripiprazole to ziprasidone in patients with schizophrenia. Kim SW, Shin IS, Kim JM, Bae KY, Yang SJ, Yoon JS. Clin Neuropharmacol. 2010 May;33(3):121-5.Abilify: 20502130 [Abilify - in process]Related Abilify Citations Metabolic parameters in patients treated with olanzapine or other atypical antipsychotics. Osuntokun OO, Millen B, Xu WI, Kryzhanovskaya LA, Robertson-Plouch C, Carlson JL, Acharya N, Corya SA. J Psychopharmacol. 2010 May 24. [Epub ahead of print]Abilify: 20498135 [Abilify - as supplied by publisher]Related Abilify Citations Efficacy and tolerability of paliperidone ER and other oral atypical antipsychotics in schizophrenia. Jones MP, Nicholl D, Trakas K. Int J Clin Pharmacol Ther. 2010 Jun;48(6):383-99.Abilify: 20497747 [Abilify - in process]Related Abilify Citations Treatment of schizophreniform disorder by aripiprazole in a female adolescent with 22q11.2 deletion syndrome. Lin CE, Hwang KS, Hsieh PH, Chia-Hsing, Tzeng NS. Prog Neuropsychopharmacol Biol Psychiatry. 2010 May 18. [Epub ahead of print] No abstract available. Abilify: 20493229 [Abilify - as supplied by publisher]Related Abilify Citations Tardive dystonia due to aripiprazole use in a neuroleptic-naive patient. Friedman JH. J Clin Psychiatry. 2010 May;71(5):652-3. No abstract available. Abilify: 20492857 [Abilify - in process]Related Abilify Citations Metabolic syndrome in patients enrolled in a clinical trial of aripiprazole in the maintenance treatment of bipolar I disorder: a post hoc analysis of a randomized, double-blind, placebo- controlled trial. Kemp DE, Calabrese JR, Tran QV, Pikalov A, Eudicone JM, Baker RA. J Clin Psychiatry. 2010 May 4. [Epub ahead of print]Abilify: 20492838 [Abilify - as supplied by publisher]Related Abilify Citations [Action of amygdala dopamine and effect of antipsychotics] Oshibuchi H, Inada K, Ishigooka J. Nihon Shinkei Seishin Yakurigaku Zasshi. 2010 Apr;30(2):93-9. Japanese. Abilify: 20491283 [Abilify - in process]Related Abilify Citations Medications Acting on the Dopaminergic System in the Treatment of Alcoholic Patients. Swift R. Curr Pharm Des. 2010 May 20. [Epub ahead of print]Abilify: 20482513 [Abilify - as supplied by publisher]Related Abilify Citations A pooled MADRS/IDS cross-correlation analysis: clinician and patient self-report assessment of improvement in core depressive symptoms with adjunctive aripiprazole. Reimherr FW, Martin ML, Eudicone JM, Marchant BK, Tran QV, Pikalov A, Marcus RN, Berman RM, Carlson BX. J Clin Psychopharmacol. 2010 Jun;30(3):300-5.Abilify: 20473067 [Abilify - in process]Related Abilify Citations Influence of DAOA gene variants on antipsychotic response after switch to aripiprazole.
Pae CU, Chiesa A, Serretti A. Psychiatry Res. 2010 May 12. [Epub ahead of print]Abilify: 20471098 [Abilify - as supplied by publisher]Related Abilify Citations Antipsychotics in pregnancy. McCauley-Elsom K, Gurvich C, Elsom SJ, Kulkarni J. J Psychiatr Ment Health Nurs. 2010 Mar;17(2):97-104.Abilify: 20465753 [Abilify - in process]Related Abilify Citations Haloperidol, spiperone, pimozide and aripiprazole reduce intracellular dopamine content in PC12 cells and rat mesencephalic cultures: Implication of inhibition of vesicular transport. Matsuo T, Izumi Y, Wakita S, Kume T, Takada-Takatori Y, Sawada H, Akaike A. Eur J Pharmacol. 2010 May 9. [Epub ahead of print]Abilify: 20460122 [Abilify - as supplied by publisher]Related Abilify Citations Effects of adjunctive treatment with aripiprazole on body weight and clinical efficacy in schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled trial. Fleischhacker WW, Heikkinen ME, Olié JP, Landsberg W, Dewaele P, McQuade RD, Loze JY, Hennicken D, Kerselaers W. Int J Neuropsychopharmacol. 2010 May 12:1-11. [Epub ahead of print]Abilify: 20459883 [Abilify - as supplied by publisher]Related Abilify Citations Gateways to clinical trials. Tomillero A, Moral MA. Methods Find Exp Clin Pharmacol. 2010 Apr;32(3):193-215.Abilify: 20448862 [Abilify - in process]Related Abilify Citations Rapid response to antipsychotic treatment on psychotic prodrome: implications from a case series. Liu CC, Sheu YH, Wu SY, Lai MC, Hwu HG. Psychiatry Clin Neurosci. 2010 Apr;64(2):202-6.Abilify: 20447014 [Abilify - in process]Related Abilify Citations The effect of metformin on anthropometrics and insulin resistance in patients receiving atypical antipsychotic agents: a meta-analysis. Ehret M, Goethe J, Lanosa M, Coleman CI. J Clin Psychiatry. 2010 Apr 6. [Epub ahead of print]Abilify: 20441727 [Abilify - as supplied by publisher]Related Abilify Citations Pharmacotherapy of Bipolar Disorder in Children and Adolescents: Recent Progress. Pfeifer JC, Kowatch RA, Delbello MP. CNS Drugs. 2010 May 4. doi: 10.2165/11533110-000000000-00000. [Epub ahead of print]Abilify: 20441242 [Abilify - as supplied by publisher]Related Abilify Citations Aripiprazole improves social interaction in Taiwanese children with pervasive developmental disorder. Huang SC, Tsai SJ, Yang HJ. Chang Gung Med J. 2010 Mar-Apr;33(2):211-5.Abilify: 20438675 [Abilify - in process]Free ArticleRelated Abilify Citations Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study. Vieta E, Owen R, Baudelet C, McQuade RD, Sanchez R, Marcus RN. Curr Med Res Opin. 2010 Jun;26(6):1485-96.Abilify: 20429835 [Abilify - in process]Related Abilify Citations Efficacy, safety and tolerability of Symbyax for acute-phase management of treatment-resistant depression. Bobo WV, Shelton RC. Expert Rev Neurother. 2010 May;10(5):651-70.Abilify: 20420487 [Abilify - in process]Related Abilify Citations Effectiveness of aripiprazole in a patient with presumed idiopathic Parkinson's disease and chronic paranoid schizophrenia. Fujino J, Tanaka H, Taniguchi N, Tabushi K. Psychiatry Clin Neurosci. 2010 Feb;64(1):108-9. No abstract available. Abilify: 20416032 [Abilify - in process]Related Abilify Citations Trial of aripiprazole in the treatment of first-episode schizophrenia. Lee HY, Ham BJ, Kang RH, Paik JW, Hahn SW, Lee MS, Lee MS. Psychiatry Clin Neurosci. 2010 Feb;64(1):38-43.Abilify: 20416024 [Abilify - in process]Related Abilify Citations Restless leg syndrome associated with olanzapine: a case series. Aggarwal S, Dodd S, Berk M. Curr Drug Saf. 2010 Apr;5(2):129-31.Abilify: 20406161 [Abilify - in process]Related Abilify Citations Compliance with Atypical Antipsychotic Triage Guidelines by Texas Poison Centers. Forrester MB. J Med Toxicol. 2010 Apr 17. [Epub ahead of print]Abilify: 20401557 [Abilify - as supplied by publisher]Related Abilify Citations Systematic reviews of assessment measures and pharmacologic treatments for agitation. Zeller SL, Rhoades RW. Clin Ther. 2010 Mar;32(3):403-25.Abilify: 20399981 [Abilify - in process]Related Abilify Citations Aripiprazole monotherapy in a patient with major depressive disorder. Yokoyama Y, Kitamura H, Someya T. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Apr 14. [Epub ahead of print] No abstract available. Abilify: 20398715 [Abilify - as supplied by publisher]Related Abilify Citations Potential control of antipsychotic-induced hyperprolactinemia and obesity in children and adolescents by aripiprazole. Lian J, Huang XF, Pai N, Deng C. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Apr 8. [Epub ahead of print] No abstract available. Abilify: 20381569 [Abilify - as supplied by publisher]Related Abilify Citations Effects of repeated and acute aripiprazole or haloperidol treatment on dopamine synthesis in the dorsal striatum of young rats: comparison to adult rats. Der-Ghazarian T, Charntikov S, Varela FA, Crawford CA, McDougall SA. J Neural Transm. 2010 May;117(5):573-83. Epub 2010 Apr 6.Abilify: 20372943 [Abilify - in process]Related Abilify Citations Optimization of aripiprazole synthesis. Leś A, Badowska-Rosłonek K, Łaszcz M, Kamieńska-Duda A, Baran P, Kaczmarek Ł. Acta Pol Pharm. 2010 Mar-Apr;67(2):151-7.Abilify: 20369792 [Abilify - indexed for MEDLINE]Related Abilify Citations Aripiprazole Improves Depressive Symptoms and Immunological Response to Antiretroviral Therapy in an HIV-Infected Subject with Resistant Depression. Cecchelli C, Grassi G, Pallanti S. Case Report Med. 2010;2010:836214. Epub 2010 Mar 30.Abilify: 20369069 [Abilify - in process]Free PMC ArticleFree textRelated Abilify Citations Mixed episodes with psychotic features. Chou JC. CNS Spectr. 2009 Nov;14(11 Suppl 11):6-8; discussion 12-4. Review. No abstract available. Abilify: 20173694 [Abilify - indexed for MEDLINE]Related Abilify Citations Antipsychotic treatments for the elderly: efficacy and safety of aripiprazole. Kohen I, Lester PE, Lam S. Neuropsychiatr Dis Treat. 2010 Mar 24;6:47-58.Abilify: 20361061 [Abilify - in process]Free PMC ArticleFree textRelated Abilify Citations D2 receptor occupancy in conscious rat brain is not significantly distinguished with [(3)H]-MNPA, [(3)H]-(+)-PHNO and [(3)H]-raclopride. Peng T, Zysk J, Dorff P, Elmore CS, Ström P, Malmquist J, Ding M, Tuke D, Werkheiser J, Widzowski D, Mrzljak L, Maier D. Synapse. 2010 Mar 22. [Epub ahead of print]Abilify: 20340171 [Abilify - as supplied by publisher]Related Abilify Citations Effect of aripiprazole on cognition in the treatment of patients with schizophrenia. Riedel M, Spellmann I, Schennach-Wolff R, Musil R, Dehning S, Cerovecki A, Opgen-Rhein M, Matz J, Seemüller F, Obermeier M, Severus E, Engel RR, Müller N, Möller HJ. Pharmacopsychiatry. 2010 Mar;43(2):50-7. Epub 2009 Dec 10.Abilify: 20336597 [Abilify - in process]Related Abilify Citations Antipsychotic drug action on SREBPs-related lipogenesis and cholesterogenesis in primary rat hepatocytes. Lauressergues E, Staels B, Valeille K, Majd Z, Hum DW, Duriez P, Cussac D. Naunyn Schmiedebergs Arch Pharmacol. 2010 May;381(5):427-39. Epub 2010 Mar 24.Abilify: 20333360 [Abilify - in process]Related Abilify Citations Aripiprazole-induced gray matter growth in a patient with major depressive disorder with panic disorder. Lai CH. J Clin Psychiatry. 2010 Mar;71(3):360-2. No abstract available. Abilify: 20331938 [Abilify - indexed for MEDLINE]Related Abilify Citations Advances in the pharmacological management of Huntington's disease. Frank S, Jankovic J. Drugs. 2010 Mar 26;70(5):561-71. doi: 10.2165/11534430-000000000-00000.Abilify: 20329804 [Abilify - in process]Related Abilify Citations Aripiprazole augmentation for the treatment of an adolescent with posttraumatic stress disorder. Yeh CC, Chou JY, Hsieh MH, Chen VC. Prog Neuropsychopharmacol Biol Psychiatry. 2010 May 30;34(4):722-3. Epub 2010 Mar 16. No abstract available. Abilify: 20298737 [Abilify - in process]Related Abilify Citations Olanzapine versus other atypical antipsychotics for schizophrenia. Komossa K, Rummel-Kluge C, Hunger H, Schmid F, Schwarz S, Duggan L, Kissling W, Leucht S. Cochrane Database Syst Rev. 2010 Mar 17;3:CD006654. Review.Abilify: 20238348 [Abilify - indexed for MEDLINE]Related Abilify Citations Pharmacotherapies for alcoholism: the old and the new. Olive MF. CNS Neurol Disord Drug Targets. 2010 Mar 1;9(1):2-4.Abilify: 20232494 [Abilify - in process]Related Abilify Citations Favourable results in treatment-resistant schizophrenic patients under combination of aripiprazole with clozapine. Mossaheb N, Spindelegger C, Asenbaum S, Fischer P, Barnas C. World J Biol Psychiatry. 2010 Mar;11(2 Pt 2):502-5.Abilify: 20218805 [Abilify - in process]Related Abilify Citations Different patterns of longitudinal changes in plasma levels of catecholamine metabolites and brain-derived neurotrophic factor after administration of atypical antipsychotics in first episode untreated schizophrenic patients. Yoshimura R, Ueda N, Hori H, Ikenouchi-Sugita A, Umene-Nakano W, Nakamura J. World J Biol Psychiatry. 2010 Mar;11(2 Pt 2):256-61.Abilify: 20218790 [Abilify - in process]Related Abilify Citations Clinical use of aripiprazole in patients with schizophrenia: A real-life setting results from the German Postmarketing Surveillance Study. Messer T, Schmauss M, Spevakne-Goeroecs T, Kungel M, Ebrecht M, Werner C, Modell S. World J Biol Psychiatry. 2010 Mar;11(2 Pt 2):231-8.Abilify: 20218786 [Abilify - in process]Related Abilify Citations Second-generation antipsychotics cause weight gain in youths. [No authors listed] Harv Ment Health Lett. 2010 Jan;26(7):7. No abstract available. Abilify: 20217902 [Abilify - indexed for MEDLINE]Related Abilify Citations Symptomatic bradycardia with oral aripiprazole and oral ziprasidone. Snarr BS, Phan SV, Garner A, VandenBerg AM, Barth KS. Ann Pharmacother. 2010 Apr;44(4):760-3. Epub 2010 Mar 9.Abilify: 20215494 [Abilify - in process]Related Abilify Citations Drug-induced Pisa syndrome associated with aripiprazole during clozapine treatment. Chen HK, Wu BJ, Shao CH. Prog Neuropsychopharmacol Biol Psychiatry. 2010 May 30;34(4):707-8. Epub 2010 Mar 6. No abstract available. Abilify: 20211216 [Abilify - in process]Related Abilify Citations Fluvoxamine for aripiprazole-associated akathisia in patients with schizophrenia: a potential role of sigma-1 receptors. Furuse T, Hashimoto K. Ann Gen Psychiatry. 2010 Mar 6;9:11.Abilify: 20205742 [Abilify - in process]Free PMC ArticleFree textRelated Abilify Citations Aripiprazole: a drug with a novel mechanism of action and possible efficacy for alcohol dependence. Vergne DE, Anton RF. CNS Neurol Disord Drug Targets. 2010 Mar 1;9(1):50-4.Abilify: 20201815 [Abilify - in process]Related Abilify Citations Early intervention with second-generation antipsychotics in first-episode psychosis: results of an 8-week naturalistic study. Josiassen RC, Shaughnessy RA, Filymer DM, Donohue AM, Kacso M, Finkel N, Curtis J, Audino B, Skuban N. Early Interv Psychiatry. 2010 Feb;4(1):57-63.Abilify: 20199481 [Abilify - in process]Related Abilify Citations Changes in medication practices for hospitalized psychiatric patients: 2009 versus 2004. Centorrino F, Ventriglio A, Vincenti A, Talamo A, Baldessarini RJ. Hum Psychopharmacol. 2010 Mar;25(2):179-86.Abilify: 20196186 [Abilify - in process]Related Abilify Citations Aripiprazole as adjunct to a mood stabilizer and citalopram in bipolar depression: a randomized placebo-controlled pilot study. Quante A, Zeugmann S, Luborzewski A, Schommer N, Langosch J, Born C, Anghelescu I, Wolf J. Hum Psychopharmacol. 2010 Mar;25(2):126-32.Abilify: 20196183 [Abilify - in process]Related Abilify Citations Neurocognition and its influencing factors in the treatment of schizophrenia-effects of aripiprazole, olanzapine, quetiapine and risperidone. Riedel M, Schennach-Wolff R, Musil R, Dehning S, Cerovecki A, Opgen-Rhein M, Matz J, Seemüller F, Obermeier M, Engel RR, Müller N, Möller HJ, Spellmann I. Hum Psychopharmacol. 2010 Mar;25(2):116-25.Abilify: 20196179 [Abilify - in process]Related Abilify Citations Switching schizophrenia patients from typical neuroleptics to aripiprazole: effects on working memory dependent functional activation. Schlagenhauf F, Dinges M, Beck A, Wüstenberg T, Friedel E, Dembler T, Sarkar R, Wrase J, Gallinat J, Juckel G, Heinz A. Schizophr Res. 2010 May;118(1-3):189-200. Epub 2010 Feb 26.Abilify: 20189356 [Abilify - in process]Related Abilify Citations Aripiprazole in anorexia nervosa and low-weight bulimia nervosa: Case reports. Trunko ME, Schwartz TA, Duvvuri V, Kaye WH. Int J Eat Disord. 2010 Feb 22. [Epub ahead of print]Abilify: 20186719 [Abilify - as supplied by publisher]Related Abilify Citations Identification of molecular targets associated with ethanol toxicity and implications in drug development. Wang LL, Yang AK, He SM, Liang J, Zhou ZW, Li Y, Zhou SF. Curr Pharm Des. 2010;16(11):1313-55.Abilify: 20184550 [Abilify - in process]Related Abilify Citations [Disappearance of paroxysmal perceptual alteration by switching to aripiprazole in a schizophrenic patient] Kondo M, Ikejiri Y, Hanatani T, Sumi N. Seishin Shinkeigaku Zasshi. 2010;112(1):23-30. Japanese. Abilify: 20184237 [Abilify - indexed for MEDLINE]Related Abilify Citations Pathological gambling and compulsive eating associated with aripiprazole. Roxanas MG. Aust N Z J Psychiatry. 2010 Mar;44(3):291. No abstract available. Abilify: 20180730 [Abilify - in process]Related Abilify Citations Benefits of switching women schizophrenic patients to aripiprazole: a case study and brief review of the literature. Kuloglu M, Ekinci O, Albayrak Y, Caykoylu A. Arch Womens Ment Health. 2010 Feb 24. [Epub ahead of print]Abilify: 20179976 [Abilify - as supplied by publisher]Related Abilify Citations Effect of aripiprazole, risperidone, and olanzapine on the acoustic startle response in Japanese chronic schizophrenia. Kishi T, Moriwaki M, Kitajima T, Kawashima K, Okochi T, Fukuo Y, Furukawa O, Naitoh H, Fujita K, Iwata N. Psychopharmacology (Berl). 2010 Apr;209(2):185-90. Epub 2010 Feb 23.Abilify: 20177883 [Abilify - in process]Related Abilify Citations Costs and outcomes associated with an aripiprazole add-on or switching open-label study in psychosis. Aitchison KJ, Mir A, Shivakumar K, McAllister VD, O'Keane V, McCrone P. J Psychopharmacol. 2010 Feb 22. [Epub ahead of print]Abilify: 20176773 [Abilify - as supplied by publisher]Related Abilify Citations Improvement of restless legs syndrome and trichotillomania with aripiprazole. Virit O, Selek S, Savas HA, Kokaçya H. J Clin Pharm Ther. 2009 Dec;34(6):723-5.Abilify: 20175807 [Abilify - indexed for MEDLINE]Related Abilify Citations Changes in positive and negative syndrome scale-derived hostility factor in adolescents with schizophrenia treated with aripiprazole: post hoc analysis of randomized clinical trial data. Robb AS, Carson WH, Nyilas M, Ali M, Forbes RA, Iwamoto T, Assunção-Talbott S, Whitehead R, Pikalov A. J Child Adolesc Psychopharmacol. 2010 Feb;20(1):33-8.Abilify: 20166794 [Abilify - indexed for MEDLINE]Related Abilify Citations Aripiprazole, hypertension, and confusion. Pitchot W, Ansseau M. J Neuropsychiatry Clin Neurosci. 2010 Winter;22(1):123.E33. No abstract available. Abilify: 20160240 [Abilify - indexed for MEDLINE]Related Abilify Citations Predictors of early worsening after switch to aripiprazole: a randomized, controlled, open-label study. Pae CU, Chiesa A, Mandelli L, Patkar AA, Gibiino S, Serretti A. Clin Drug Investig. 2010;30(3):187-93. doi: 10.2165/11533060-000000000-00000.Abilify: 20155991 [Abilify - indexed for MEDLINE]Related Abilify Citations Aripiprazole for the maintenance treatment of bipolar I disorder: A review. McIntyre RS. Clin Ther. 2010;32 Suppl 1:S32-8. Review.Abilify: 20152551 [Abilify - indexed for MEDLINE]Related Abilify Citations Aripiprazole in schizophrenia and schizoaffective disorder: A review. Stip E, Tourjman V. Clin Ther. 2010;32 Suppl 1:S3-20. Review.Abilify: 20152550 [Abilify - indexed for MEDLINE]Related Abilify Citations The role of aripiprazole in Canada: A review of clinical and drug discontinuation data. Foreword. McIntyre RS. Clin Ther. 2010;32 Suppl 1:S1-2. No abstract available. Abilify: 20152548 [Abilify - indexed for MEDLINE]Related Abilify Citations Evidence-based use of second-generation antipsychotics in a state Medicaid pediatric population, 2001-2005. Pathak P, West D, Martin BC, Helm ME, Henderson C. Psychiatr Serv. 2010 Feb;61(2):123-9.Abilify: 20123816 [Abilify - indexed for MEDLINE]Related Abilify Citations Use of aripiprazole in clozapine induced enuresis: report of two cases. Lee MJ, Kim CE. J Korean Med Sci. 2010 Feb;25(2):333-5. Epub 2010 Jan 19.Abilify: 20119596 [Abilify - indexed for MEDLINE]Free PMC ArticleFree textRelated Abilify Citations The association between class of antipsychotic and rates of hospitalization: results of a retrospective analysis of data from the 2005 Medicare current beneficiary survey. Kennedy J, Tien YY, Cohen LJ, Sclar DA, Liu D, Blodgett EG, Engle J. Clin Ther. 2009 Dec;31(12):2931-9.Abilify: 20110033 [Abilify - indexed for MEDLINE]Related Abilify Citations [Aripiprazole-induced stuttering treated with risperidone.] Rocha FF. Rev Bras Psiquiatr. 2009 Dec;31(4):388. Portuguese. No abstract available. Abilify: 20098832 [Abilify - in process]Free ArticleRelated Abilify Citations Safety and Tolerability of Adjunctive Aripiprazole in Major Depressive Disorder: A Pooled Post Hoc Analysis (studies CN138-139 and CN138-163). Nelson JC, Thase ME, Trivedi MH, Fava M, Han J, Van Tran Q, Pikalov A, Qi Y, Carlson BX, Marcus RN, Berman RM. Prim Care Companion J Clin Psychiatry. 2009;11(6):344-352.Abilify: 20098527 [Abilify - as supplied by publisher]Free PMC ArticleFree textRelated Abilify Citations Functional SNPs in Genes Encoding the 5-HT2A Receptor Modify the Affinity and Potency of Several Atypical Antipsychotic Drugs. Davies MA, Conley Y, Roth BL. Biol Res Nurs. 2010 Jan 21. [Epub ahead of print]Abilify: 20097665 [Abilify - as supplied by publisher]Related Abilify Citations Identification of selected therapeutic agents as inhibitors of carboxylesterase 1: potential sources of metabolic drug interactions. Zhu HJ, Appel DI, Peterson YK, Wang Z, Markowitz JS. Toxicology. 2010 Apr 11;270(2-3):59-65. Epub 2010 Jan 25.Abilify: 20097249 [Abilify - indexed for MEDLINE]Related Abilify Citations The 5-HT(7) receptor as a mediator and modulator of antidepressant-like behavior. Sarkisyan G, Roberts AJ, Hedlund PB. Behav Brain Res. 2010 May 1;209(1):99-108. Epub 2010 Jan 25.Abilify: 20097233 [Abilify - indexed for MEDLINE]Related Abilify Citations Gateways to clinical trials. Tomillero A, Moral MA. Methods Find Exp Clin Pharmacol. 2009 Nov;31(9):597-633.Abilify: 20094643 [Abilify - indexed for MEDLINE]Related Abilify Citations Cariprazine (RGH-188), a dopamine D(3) receptor-preferring, D(3)/D(2) dopamine receptor antagonist-partial agonist antipsychotic candidate: in vitro and neurochemical profile. Kiss B, Horváth A, Némethy Z, Schmidt E, Laszlovszky I, Bugovics G, Fazekas K, Hornok K, Orosz S, Gyertyán I, Agai-Csongor E, Domány G, Tihanyi K, Adham N, Szombathelyi Z. J Pharmacol Exp Ther. 2010 Apr;333(1):328-40. Epub 2010 Jan 21.Abilify: 20093397 [Abilify - indexed for MEDLINE]Related Abilify Citations Zotepine versus other atypical antipsychotics for schizophrenia. Komossa K, Rummel-Kluge C, Hunger H, Schmid F, Schwarz S, Kissling W, Leucht S. Cochrane Database Syst Rev. 2010 Jan 20;(1):CD006628. Review.Abilify: 20091601 [Abilify - indexed for MEDLINE]Related Abilify Citations Quetiapine versus other atypical antipsychotics for schizophrenia. Komossa K, Rummel-Kluge C, Schmid F, Hunger H, Schwarz S, Srisurapanont M, Kissling W, Leucht S. Cochrane Database Syst Rev. 2010 Jan 20;(1):CD006625. Review.Abilify: 20091600 [Abilify - indexed for MEDLINE]Related Abilify Citations Amisulpride versus other atypical antipsychotics for schizophrenia. Komossa K, Rummel-Kluge C, Hunger H, Schmid F, Schwarz S, Silveira da Mota Neto JI, Kissling W, Leucht S. Cochrane Database Syst Rev. 2010 Jan 20;(1):CD006624. Review.Abilify: 20091599 [Abilify - indexed for MEDLINE]Related Abilify Citations Therapeutic options for treatment-resistant depression. Shelton RC, Osuntokun O, Heinloth AN, Corya SA. CNS Drugs. 2010 Feb 1;24(2):131-61. doi: 10.2165/11530280-000000000-00000. Review.Abilify: 20088620 [Abilify - indexed for MEDLINE]Related Abilify Citations Effects of aripiprazole on MK-801-induced prepulse inhibition deficits and mitogen-activated protein kinase signal transduction pathway. Ishii D, Matsuzawa D, Kanahara N, Matsuda S, Sutoh C, Ohtsuka H, Nakazawa K, Kohno M, Hashimoto K, Iyo M, Shimizu E. Neurosci Lett. 2010 Feb 26;471(1):53-7. Epub 2010 Jan 18.Abilify: 20083164 [Abilify - indexed for MEDLINE]Related Abilify Citations Neuroleptic malignant syndrome with the addition of aripiprazole to clozapine. Dassa D, Drai-Moog D, Samuelian JC. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Mar 17;34(2):427-8. Epub 2010 Jan 17. No abstract available. Abilify: 20080143 [Abilify - indexed for MEDLINE]Related Abilify Citations Treatment with aripiprazole for hyperprolactinemia induced by pituitary microadenoma in a bipolar I disorder patient. Chen ST, Hsiao YL. J Clin Psychopharmacol. 2010 Feb;30(1):78-80. No abstract available. Abilify: 20075655 [Abilify - indexed for MEDLINE]Related Abilify Citations Aripiprazole induced acute dystonia after discontinuation of a stimulant medication. McLaren JL, Cauble S, Barnett RJ. J Clin Psychopharmacol. 2010 Feb;30(1):77-8. No abstract available. Abilify: 20075654 [Abilify - indexed for MEDLINE]Related Abilify Citations Priapism associated with antipsychotics: role of alpha1 adrenoceptor affinity. Andersohn F, Schmedt N, Weinmann S, Willich SN, Garbe E. J Clin Psychopharmacol. 2010 Feb;30(1):68-71.Abilify: 20075651 [Abilify - indexed for MEDLINE]Related Abilify Citations The risk of death among adult participants in trials of antipsychotic drugs in schizophrenia. Isaac M, Koch A. Eur Neuropsychopharmacol. 2010 Mar;20(3):139-45. Epub 2010 Jan 6.Abilify: 20053539 [Abilify - in process]Related Abilify Citations Co-operativity in agonist binding at the D2 dopamine receptor: evidence from agonist dissociation kinetics. Kara E, Lin H, Strange PG. J Neurochem. 2010 Mar;112(6):1442-53. Epub 2009 Dec 24.Abilify: 20050980 [Abilify - indexed for MEDLINE]Related Abilify Citations Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs. Morrato EH, Druss B, Hartung DM, Valuck RJ, Allen R, Campagna E, Newcomer JW. Arch Gen Psychiatry. 2010 Jan;67(1):17-24.Abilify: 20048219 [Abilify - indexed for MEDLINE]Related Abilify Citations Efficacy of the atypical antipsychotic aripiprazole in d-amphetamine-based preclinical models of mania. Mavrikaki M, Nomikos GG, Panagis G. Int J Neuropsychopharmacol. 2010 May;13(4):541-8. Epub 2010 Jan 5.Abilify: 20047715 [Abilify - in process]Related Abilify Citations Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials. Lieb K, Völlm B, Rücker G, Timmer A, Stoffers JM. Br J Psychiatry. 2010 Jan;196(1):4-12. Review.Abilify: 20044651 [Abilify - indexed for MEDLINE]Related Abilify Citations Treatment of psychotic symptoms in bipolar disorder with aripiprazole monotherapy: a meta-analysis. Fountoulakis KN, Gonda X, Vieta E, Schmidt F. Ann Gen Psychiatry. 2009 Dec 31;8:27.Abilify: 20043829 [Abilify - in process]Free PMC ArticleFree textRelated Abilify Citations Aripiprazole in children and adolescents with Tourette's disorder: an open-label safety and tolerability study. Lyon GJ, Samar S, Jummani R, Hirsch S, Spirgel A, Goldman R, Coffey BJ. J Child Adolesc Psychopharmacol. 2009 Dec;19(6):623-33.Abilify: 20035580 [Abilify - indexed for MEDLINE]Related Abilify Citations The effect of dopamine partial agonists on the nicotine dependency in patients with schizophrenia. Kim SH, Han DH, Joo SY, Min KJ. Hum Psychopharmacol. 2010 Mar;25(2):187-90.Abilify: 20033907 [Abilify - in process]Related Abilify Citations Aripiprazole and adolescent schizophrenia: a simple neuroleptic. No comparison with standard neuroleptic in adolescents. [No authors listed] Prescrire Int. 2009 Dec;18(104):251. No abstract available. Abilify: 20025091 [Abilify - indexed for MEDLINE]Related Abilify Citations Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trials. Kane JM, Barnes TR, Correll CU, Sachs G, Buckley P, Eudicone J, McQuade R, Van Tran Q, Pikalov A 3rd, Assunção-Talbott S. J Psychopharmacol. . [Epub ahead of print]Abilify: 20008446 [Abilify - as supplied by publisher]Related Abilify Citations Pediatric bipolar disorder. Carbray MJ, McGuinness T. J Psychosoc Nurs Ment Health Serv. 2009 Dec;47(12):22-6. doi: 10.3928/02793695-20091103-02.Abilify: 20000279 [Abilify - indexed for MEDLINE]Related Abilify Citations Managing partial response or nonresponse: switching, augmentation, and combination strategies for major depressive disorder. Papakostas GI. J Clin Psychiatry. 2009;70 Suppl 6:16-25. Review.Abilify: 19922740 [Abilify - indexed for MEDLINE]Related Abilify Citations Effects of a positive allosteric modulator of mGluR5 ADX47273 on conditioned avoidance response and PCP-induced hyperlocomotion in the rat as models for schizophrenia. Schlumberger C, Pietraszek M, Gravius A, Danysz W. Pharmacol Biochem Behav. 2010 Mar;95(1):23-30. Epub 2009 Dec 5.Abilify: 19995568 [Abilify - in process]Related Abilify Citations